Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples